Publications by authors named "Kevin Bock"

Claim this Profile
N
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.
R Dilshan Malewana, Victoria Stalls, Aaron May, Xiaozhi Lu, David R Martinez, Kevin W Bock

Sci Transl Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protection.
Mallory L Myers, John R Gallagher, De'Marcus D Woolfork, Noah D Khorrami, William B Park, Kevin W Bock

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy.
Yongjun Sui, Hanne Andersen, Jianping Li, Tanya Hoang, Mahnaz Minai, Kevin W Bock

Vaccine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates.
R Dilshan Malewana, Victoria Stalls, Aaron May, Xiaozhi Lu, David R Martinez, Kevin W Bock

bioRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates.
Juan I Moliva, Shayne F Andrew, Barbara J Flynn, Danielle A Wagner, Kathryn E Foulds, Kevin W Bock

bioRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Community SARS-CoV-2 Case Counts and Instantaneous Reproductive Number to Predict Short-Term COVID-19 Hospital Admission Volumes.
Michael I Oppenheim, Juan Rada, Abraham Saraya, Kevin R Bock, John D'Angelo

Am J Epidemiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus.
Mallory L Myers, John R Gallagher, De'Marcus D Woolfork, Regan K Stradtmann-Carvalho, Samantha Maldonado-Puga, Kevin W Bock

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a Machine Learning Algorithm to Develop and Validate a Prediction Model for Ambulatory Non-Arrivals.
Kevin Coppa, Eun Ji Kim, Michael I Oppenheim, Kevin R Bock, Theodoros P Zanos

J Gen Intern Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Identification of Patients with Advanced Illness.
Rajdeep Brar, M Isabel Friedman, Nicholas Dacosta, Alexander Rimar, Jessica Cohen, Kevin Bock

AMIA Annu Symp Proc· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies.
Mallory L Myers, John R Gallagher, Alexander J Kim, Walker H Payne, Samantha Maldonado-Puga, Kevin W Bock

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus.
Mallory L Myers, John R Gallagher, De'Marcus D Woolfork, Regan K Stradtmann-Carvalho, Samantha Maldonado-Puga, Kevin W Bock

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine.
Dapeng Li, David R Martinez, Alexandra Schäfer, Haiyan Chen, Maggie Barr, Kevin W Bock

Nat Commun· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques.
Yongjun Sui, Jianping Li, Hanne Andersen, Roushu Zhang, Sunaina K Prabhu, Kevin W Bock

PNAS Nexus· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron.
Matthew Gagne, Juan I Moliva, Kathryn E Foulds, Shayne F Andrew, Barbara J Flynn, Kevin W Bock

Cell· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine.
Dapeng Li, David R Martinez, Alexandra Schäfer, Haiyan Chen, Maggie Barr, Kevin W Bock

bioRxiv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung.
Matthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, Kathryn E Foulds, Danielle A Wagner, Kevin W Bock

Cell· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates.
Kizzmekia S Corbett, Matthew Gagne, Danielle A Wagner, Sarah O' Connell, Sandeep R Narpala, Kevin W Bock

Science· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
Kizzmekia S Corbett, Anne P Werner, Sarah O' Connell, Matthew Gagne, Lilin Lai, Kevin W Bock

Nat Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection.
Michelle Meyer, Yuan Wang, Darin Edwards, Gregory R Smith, Aliza B Rubenstein, Kevin W Bock

J Clin Invest· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway.
Matthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, Kathryn E Foulds, Danielle A Wagner, Kevin W Bock

bioRxiv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor.
Chunfu Yang, Lei Lei, John W Marshall Collins, Michael Briones, Li Ma, Kevin W Bock

Nat Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.
Kizzmekia S Corbett, Martha C Nason, Britta Flach, Matthew Gagne, Sarah O'Connell, Kevin W Bock

Science· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study.
Mark Jarrett, Warren Licht, Kevin Bock, Zenobia Brown, Jamie Hirsch

JMIRx Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.
Anthony T DiPiazza, Sarah R Leist, Olubukola M Abiona, Juan I Moliva, Anne Werner, Kevin W Bock

Immunity· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates.
Kizzmekia S Corbett, Matthew Gagne, Danielle A Wagner, Sarah O' Connell, Sandeep R Narpala, Kevin W Bock

bioRxiv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis